Storia della carriera di Lynn Gallant
Precedenti posizioni note di Lynn Gallant
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 22/02/2023 | 01/05/2023 |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Lynn Gallant
| University of New England | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Canada | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Lynn Gallant
- Esperienza
